Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer

Gynecologic Oncology

Volumn 93, Issue 3, 2004, Pages 615-620

  Olson, S H ^a   Carlson, M D A ^a   Ostrer, H ^b   Harlap, S ^c   Stone, A ^d   Winters, M ^d   Ambrosone, C B ^e  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Columbia   (United States)

^d NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Genetic polymorphisms; Manganese superoxide dismutase; Myeloperoxidase; NAD(P)H:oxidoreductase 1; Ovarian carcinoma

Indexed keywords

MYELOPEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SIGNAL PEPTIDE; SUPEROXIDE DISMUTASE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; EXON; FEMALE; GEL ELECTROPHORESIS; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OVARY CANCER; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SUBSTITUTION REACTION;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); OVARIAN NEOPLASMS; OXIDATIVE STRESS; PEROXIDASE; POLYMORPHISM, GENETIC; RISK FACTORS; SUPEROXIDE DISMUTASE; VARIATION (GENETICS);

EID: 2942668384     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.03.027     Document Type: Article

References (36)

1. Whittemore A.S., Harris R., Itnyre J. Collaborative Ovarian Cancer Group Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies: II. Invasive epithelial ovarian cancers in white women. Am. J. Epidemiol. 136:1992;1184-1203
2. Ness R.B., Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J. Natl. Cancer Inst. 91:1999;1459-1467
3. Tamate K., Sengoku K., Ishikawa M. The role of superoxide dismutase in the human ovary and fallopian tube. J. Obstet. Gynaecol. 21:1995;401-409
4. Sugino N., Telleria C.M., Gibori G. Differential regulation of copper-zinc superoxide dismutase and manganese superoxide dismutase in the rat corpus luteum: induction of manganese superoxide dismutase messenger ribonucleic acid by inflammatory cytokines. Biol. Reprod. 59:1998;208-215
5. Tanaguchi N., Ishikawa M., Kawaguchi T., Fujii J., Suzuki K., Nakata T. Expression of Mn-superoxide dismutase in carcinogenesis. Tohoku J. Exp. Med. 168:1992;105-111
6. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimizu Y., Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem. Biophys. Res. Commun. 226:1996;561-565
7. Rosenblum J.S., Gilula N.B., Lerner R.A. On signal sequence polymorphisms and diseases of distribution. Proc. Natl. Acad. Sci. 93:1996;4471-4473
8. Hiroi S., Harada H., Nishi H., Satoh M., Nagai R., Kimura A. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem. Biophys. Res. Commun. 261:1999;332-339
9. Ambrosone C.B., Freudenheim J.L., Thompson P.A., Bowman E., Vena J.E., Marshall J.R., et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 59:1999;602-606
10. Woodson K., Tangrea J.A., Lehman T.A., Modali R., Taylor K.M., Snyder K., et al. Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Causes Control. 14:2003;513-518
11. Trush M.A., Seed J.L., Kensler T.W. Oxidant-dependent metabolic activation of polycyclic aromatic hydrocarbons by phorbol ester-stimulated human polymorphonuclear leukocytes: possible link between inflammation and cancer. Proc. Natl. Acad. Sci. 82:1985;5194-5198
12. Van Rensburg C.E.J., Van Staden A.M., Anderson R., Van Rensburg E.J. Hypochlorous acid potentiates hydrogen peroxide-mediated DNA-strand breaks in human mononuclear leucocytes. Mutat. Res. 265:1992;255-261
13. Winterbourn C.C., Vissers M.C.M., Kettle A.J. Myeloperoxidase. Curr. Opin. Hematol. 7:2000;53-58
14. Brannstrom M., Brannstrom V.X., Norman R.J., McClure N. Localization of leukocyte subsets in the follicle wall and in the corpus luteum throughout the human menstrual cycle. Fertil. Steril. 61:1994;488-495
15. Chang R.J., Gougeon A., Erickson G.F. Evidence for a neutrophil- interleukin-8 system in human folliculogenesis. Am. J. Obstet. Gynecol. 178:1998;650-657
16. Ujioka T., Matsukawa A., Tanaka N., Matsuura K., Yoshinaga M., Okamura H. Interleukin-8 as an essential factor in the human chorionic gonadotropin-induced rabbit ovulatory process: interleukin-8 induces neutrophil accumulation and activation in ovulation. Biol. Reprod. 58:1998;526-530
17. Song M., Santanam N. Increased myeloperoxide and lipid peroxide-modified protein in gynecological malignancies. Antioxid. Redox Signal. 3:2001;1139-1146
18. Piedrafita F.J., Molander R.B., Vansant G., Orlova E.A., Pfahl M., Reynolds W.F. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem. 271:1996;14412-14420
19. Cadenas E. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem. Pharmacol. 49:1995;127-140
20. Joseph P., Xie T., Xu Y., Jaiswal A.K. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase): expression, regulation, and role in cancer. Oncol. Res. 6:1994;525-532
21. Zappa F., Ward T., Butler J., Pedrinis E., McGown A. Overexpression of NAD(P)H:quinone oxidoreductase 1 in human reproductive system. J. Histochem. Cytochem. 49:2001;1187-1188
22. Traver R.D., Horikoshi T., Danenberg K.D., Stadlbauer T.H.W., Danenberg P.V., Ross D., et al. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res. 52:1992;797-802
23. Siegel D., McGuinness S.M., Winski S.L., Ross D. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1. Pharmacogenetics. 9:1999;113-121
24. Ross D., Traver R.D., Siegel D., Kuehl B.L., Misra V., Rauth A.M. A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity (letter). Br. J. Cancer. 74:1996;995-996
25. Olson S.H., Mignone L., Harlap S. Selection of control groups using a commercial database and random digit dialing. Am. J. Epidemiol. 152:2000;585-592
26. Breslow N.E., Day N.E. Statistical methods in cancer research. 1980;225 International Agency for Cancer Research, Lyon
27. Harlap S., Olson S., Akhmedkhnov A., Barakat R.R., Caputo T., Sanchez D., et al. Epithelial ovarian carcinoma and European birthplace of grandparents. Gynecol. Oncol. 81:2001;25-32
28. Cavalli-Sforza L.L., Menozzi P., Piazza A. The history and geography of human genes. 1994;Princeton Univ. Press, Princeton
29. Hong Y.-C., Lee K.-H., Yi C.-H., Ha E.-H., Christiani D.C. Genetic susceptibility of term pregnant women to oxidative damage. Toxicol. Lett. 129:2002;255-262
30. Mitrunen K., Sillanpaa P., Kataja V., Eskelinen M., Kosma V.-M., Benhamou S., et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis. 22:2001;827-829
31. Wang L.I., Miller D.P., Sai Y., Liu G., Su L., Wain J.C., et al. Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk. JNCI. 93:2001;1818-1821
32. -463 G→A polymorphism and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 11:2002;1550-1554
33. -463 G→A polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol. Biomarkers Prev. 11:2002;1555-1559
34. Chevrier I., Stucker I., Houllier A.-M., Cenee S., Beaune P., Laurent-Puig P., et al. Myeloperoxidase: new polymorphisms and relation with lung cancer risk. Pharmacogenetics. 13:2003;729-739
35. Van Landeghem G.F., Tabatabaie P., Kucinskas V., Saha N., Beckman G. Ethnic variation in the mitochondrial targeting sequence polymorphism of MnSOD. Hum. Hered. 49:1999;190-193
36. Stoehlmacher J., Ingles S.A., Park D.J., Zhang W., Lenz H.-J. The -9ala/-9val polymorphism in the mitochondrial targeting sequence of the manganese superoxide dismutase gene (MnSOD) is associated with age among Hispanics with colorectal carcinoma. Oncol. Rep. 9:2002;235-238